AbbVie Inc. diskutieren
AbbVie Inc.
WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Aktie / Pharmazeutika / Large Cap /
213,10 €
0,52 %
AbbVie (ABBV) had its price target raised by Bank of America Corporation from $234.00 to $276.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its price target raised by BMO Capital Markets from $258.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its price target raised by Canaccord Genuity Group Inc. from $273.00 to $282.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its price target raised by Cantor Fitzgerald from $265.00 to $285.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its "overweight" rating reaffirmed by Morgan Stanley.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its price target raised by Guggenheim from $261.00 to $288.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in Expeditors International of Washington Inc. diskutieren